Effect of Dupilumab on Laboratory Parameters in Adolescents With Atopic Dermatitis: Results from a Randomized Placebo-Controlled Phase 3 Clinical Trial
mediaposted on 25.02.2021, 22:42 authored by Elaine Siegfried, Thomas Bieber, Eric L. Simpson, Amy S. Paller, Lisa A. Beck, Mark Boguniewicz, Lynda C. Schneider, Faisal A. Khokhar, Zhen Chen, Randy Prescilla, Paola Mina-Osorio, Ashish Bansal
The above video abstract represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite).